A Clinical Feasibility Study to Assess the Performance of a Latex Condom in Healthy Monogamous Couples.
NCT05073770 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2021-10-11
Summary
The U.S. Centers for Disease Control and Prevention has recommended the male latex condom as the best physical barrier for preventing HIV and sexually transmitted disease (STD) transmission. Condoms are a safe and effective form of contraception that have 98% effectiveness in protecting against STD and pregnancy. However, evidence shows that if a condom does not fit properly, its impact can reduce to 85% or less, as it may slip off during sex or during removal of the penis from the vagina or breaks during intercourse.
Condoms need to fit correctly to guard against fluids and exposed skin which could lead to STD contraction or pregnancy. To choose the right size, the girth (the width of an erect penis) is the most important factor, not length. However, most condom companies do not list their nominal width, let alone base their sizes off girth. In addition, most brands usually offer XL as only 56 mm based on a misconception that one size fits all and that "XL" condoms are big enough. But that is far from the truth, and several men complain about the lack of simplicity and intuitiveness when finding a condom that fits them.
To address this gap, after a long two years of development, Titan company was able to engineer four distinct sizes so that each man can easily find the condom he needs. This study aims to obtain a preliminary estimate of slippage and breakage of Titan's new condom (64mm or 69mm) during use.
Conditions
- Performance of a New Condom
Interventions
- DEVICE
-
Titan Condom
The test condoms have the following specifications throughout the study: 1. The plain 64mm condom (i.e., N64): Length 223 ±5mm, width 64±1mm, thickness (single wall) 0.070± 0.005mm, and beading thickness 1.25±0.05mm. 2. The plain 69mm condom (i.e., N69): Length 223 ±5mm, Width 69±1mm, Thickness (single wall) 0.070± 0.005mm, Beading thickness 1.25±0.05mm.
Sponsors & Collaborators
-
STATCure Consulting Services Inc.
collaborator UNKNOWN -
Titan Condoms, LLC
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-10-31
- Primary Completion
- 2022-01-31
- Completion
- 2022-03-31
More Related Trials
-
A Clinical Investigation to Assess the Performance of Natural Rubber Latex Condoms in Couples
NCT03739190 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of 2 Synthetic Nitrile Male Condoms Compared to a Standard Latex Male Condom
NCT05912283 ·Status: COMPLETED ·Phase: NA
-
A 3-way Crossover Clinical Investigation to Assess the Performance of Two Different Sized Polyurethane Condoms Versus a Latex Condom in Healthy Monogamous Couples.
NCT06557499 ·Status: RECRUITING ·Phase: NA
-
Evaluation of Tolerance and Acceptability of a Coated Condom
NCT01619397 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Performance and Acceptability of a Synthetic Polyisoprene Male Condom Compared to a Natural Rubber Latex Condom
NCT06595836 ·Status: RECRUITING ·Phase: NA
-
User Preference Study of an Experimental HydroGlyde Male Condom Compared to a Commercial Latex Male Condom
NCT05308992 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Multicenter, Open-Label, Non-Comparative Study of the Safety and Contraceptive Efficacy of the Woman's Condom
NCT01223313 ·Status: COMPLETED ·Phase: NA
-
A Safety and Acceptability Study of a Vaginal Ring Microbicide Delivery Method
NCT00469170 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Testing Use of Condoms on Regression of Cervical Intraepithelial Neoplasia
NCT02907333 ·Status: COMPLETED ·Phase: NA
-
Rectal Safety and Acceptability Study of Tenofovir 1% Gel
NCT01232803 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Acceptability of a Vaginal Microbicide
NCT00111943 ·Status: COMPLETED ·Phase: PHASE2
-
Development of Adherence Biomarkers for Multiple Microbicide and Multipurpose Prevention Technology (MPT) Dosage Forms
NCT02569697 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerance and Acceptability Trial of the Invisible Condom® in Healthy Women
NCT00136643 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Study of Non-Surgical MC Device for Adolescent Male Population Including Contraindicated Subjects
NCT02581722 ·Status: UNKNOWN ·Phase: NA
-
A 24 Hour Occlusive Single Patch Test to Assess Acute Tolerance of Pre Lubricated Condom on a Panel of Healthy Adult Subjects
NCT02864966 ·Status: COMPLETED ·Phase: NA
-
SPL7013 Gel - Male Tolerance Study
NCT00370357 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant Women
NCT01490671 ·Status: WITHDRAWN ·Phase: PHASE2
-
Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected Women
NCT00594373 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of UC-781 Vaginal Microbicide
NCT00446979 ·Status: COMPLETED ·Phase: PHASE1
-
Prospective, Verification Study to Assess Condom Fit Across Polyurethane (PU) and Natural Rubber Latex (NRL) Condoms
NCT06777797 ·Status: COMPLETED ·Phase: NA
-
Safety of Acidform Lubricant in HIV-Uninfected Women
NCT00850837 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study to Evaluate the Performance of Synthetic Polyurethane Male Condoms
NCT05536336 ·Status: TERMINATED ·Phase: NA
-
Randomised Controlled Trial of Condoms Plus Additional Lubrication
NCT00369213 ·Status: COMPLETED ·Phase: PHASE4
-
A Healthcare Economic Study of the Click Sexual Health Test
NCT04099199 ·Status: COMPLETED
-
Evaluation of Synthetic Nitrile Male Condom Compared to Standard Latex Male Condom
NCT06079060 ·Status: COMPLETED ·Phase: NA